Craig H. Mallinckrodt, PhD

Original Research

Assessing Onset of Treatment Benefit in Depression and Anxiety: Conceptual Considerations

August 15, 2009

Eugene M. Laska, Craig H. Mallinckrodt, Jim C. Mundt, et al

Original Research

A Randomized, Double-Blind Study of Increasing or Maintaining Duloxetine Dose in Patients Without Remission of Major Depressive Disorder After Initial Duloxetine Therapy

September 30, 2008

Susan G. Kornstein, David L. Dunner, Adam L. Meyers, et al

Original Research

The Significance of Treating Somatic Symptoms on Functional Outcome Improvement in Patients With Major Depressive Disorder: A Post Hoc Analysis of 2 Trials

August 15, 2008

Thomas N. Wise, Adam L. Meyers, Durisala Desaiah, et al

Original Research

A Comparison of Initial Duloxetine Dosing Strategies in Patients With Major Depressive Disorder

December 14, 2007

Virgil G. Whitmyer, David L. Dunner, Susan G. Kornstein, et al

Original Research

Duloxetine in the Treatment of Major Depressive Disorder: Comparisons of Safety and Efficacy in U.S. Hispanic and Majority Caucasian Patients

September 15, 2006

Roberto Lewis-Fernández, Carlos Blanco, Craig H. Mallinckrodt, et al

Original Research

The Safety and Tolerability of Duloxetine Compared With Paroxetine and Placebo: A Pooled Analysis of 4 Clinical Trials

August 15, 2006

J. Craig Nelson, Yili Lu, Pritchett, et al

Original Research

Duloxetine Efficacy for Major Depressive Disorder in Male vs. Female Patients: Data From 7 Randomized, Double-Blind, Placebo-Controlled Trials

May 15, 2006

Susan G. Kornstein, Madelaine M. Wohlreich, Craig H. Mallinckrodt, et al

Original Research

Sexual Functioning Assessed in 4 Double-Blind Placebo- and Paroxetine-Controlled Trials of Duloxetine for Major Depressive Disorder

June 15, 2005

Pedro L. Delgado, Stephen K. Brannan, Craig H. Mallinckrodt, et al

Original Research

The Effect of Duloxetine on Painful Physical Symptoms in Depressed Patients: Do Improvements in These Symptoms Result in Higher Remission Rates?

April 1, 2004

Maurizio Fava, Craig H. Mallinckrodt, Michael J. Detke, et al

Original Research

Duloxetine in the Long-Term Treatment of Major Depressive Disorder

October 15, 2003

Joel Raskin, David J. Goldstein, Craig H. Mallinckrodt, et al

Original Research

Duloxetine: A New Treatment for the Emotional and Physical Symptoms of Depression

February 1, 2003

Craig H. Mallinckrodt, David J. Goldstein, Michael J. Detke, et al

Assessing Onset of Treatment Benefit in Depression and Anxiety: Conceptual Considerations

A Randomized, Double-Blind Study of Increasing or Maintaining Duloxetine Dose in Patients Without Remission of Major Depressive Disorder After Initial Duloxetine Therapy

The Significance of Treating Somatic Symptoms on Functional Outcome Improvement in Patients With Major Depressive Disorder: A Post Hoc Analysis of 2 Trials

A Comparison of Initial Duloxetine Dosing Strategies in Patients With Major Depressive Disorder

Duloxetine in the Treatment of Major Depressive Disorder: Comparisons of Safety and Efficacy in U.S. Hispanic and Majority Caucasian Patients

The Safety and Tolerability of Duloxetine Compared With Paroxetine and Placebo: A Pooled Analysis of 4 Clinical Trials

Duloxetine Efficacy for Major Depressive Disorder in Male vs. Female Patients: Data From 7 Randomized, Double-Blind, Placebo-Controlled Trials

Sexual Functioning Assessed in 4 Double-Blind Placebo- and Paroxetine-Controlled Trials of Duloxetine for Major Depressive Disorder

The Effect of Duloxetine on Painful Physical Symptoms in Depressed Patients: Do Improvements in These Symptoms Result in Higher Remission Rates?

Duloxetine in the Long-Term Treatment of Major Depressive Disorder

Duloxetine: A New Treatment for the Emotional and Physical Symptoms of Depression

ELSEWHERE:

FOLLOW US:

Craig H. Mallinckrodt, PhD

Assessing Onset of Treatment Benefit in Depression and Anxiety: Conceptual Considerations

A Randomized, Double-Blind Study of Increasing or Maintaining Duloxetine Dose in Patients Without Remission of Major Depressive Disorder After Initial Duloxetine Therapy

The Significance of Treating Somatic Symptoms on Functional Outcome Improvement in Patients With Major Depressive Disorder: A Post Hoc Analysis of 2 Trials

A Comparison of Initial Duloxetine Dosing Strategies in Patients With Major Depressive Disorder

Duloxetine in the Treatment of Major Depressive Disorder: Comparisons of Safety and Efficacy in U.S. Hispanic and Majority Caucasian Patients

The Safety and Tolerability of Duloxetine Compared With Paroxetine and Placebo: A Pooled Analysis of 4 Clinical Trials

Duloxetine Efficacy for Major Depressive Disorder in Male vs. Female Patients: Data From 7 Randomized, Double-Blind, Placebo-Controlled Trials

Sexual Functioning Assessed in 4 Double-Blind Placebo- and Paroxetine-Controlled Trials of Duloxetine for Major Depressive Disorder

The Effect of Duloxetine on Painful Physical Symptoms in Depressed Patients: Do Improvements in These Symptoms Result in Higher Remission Rates?

Duloxetine in the Long-Term Treatment of Major Depressive Disorder

Duloxetine: A New Treatment for the Emotional and Physical Symptoms of Depression

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles